vs
Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.
SCANSOURCE, INC. is the larger business by last-quarter revenue ($766.5M vs $384.8M, roughly 2.0× P3 Health Partners Inc.). SCANSOURCE, INC. runs the higher net margin — 2.2% vs -19.6%, a 21.8% gap on every dollar of revenue. On growth, P3 Health Partners Inc. posted the faster year-over-year revenue change (3.8% vs 2.5%). Over the past eight quarters, SCANSOURCE, INC.'s revenue compounded faster (0.9% CAGR vs -0.5%).
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.
PIII vs SCSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $384.8M | $766.5M |
| Net Profit | $-75.5M | $16.5M |
| Gross Margin | — | 13.4% |
| Operating Margin | -40.0% | 2.3% |
| Net Margin | -19.6% | 2.2% |
| Revenue YoY | 3.8% | 2.5% |
| Net Profit YoY | -28.8% | -3.3% |
| EPS (diluted) | $-23.08 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $384.8M | $766.5M | ||
| Q3 25 | $345.3M | $739.6M | ||
| Q2 25 | $355.8M | $812.9M | ||
| Q1 25 | $373.2M | $704.8M | ||
| Q4 24 | $370.7M | $747.5M | ||
| Q3 24 | $362.1M | $775.6M | ||
| Q2 24 | $379.2M | $746.1M | ||
| Q1 24 | $388.5M | $752.6M |
| Q4 25 | $-75.5M | $16.5M | ||
| Q3 25 | $-31.6M | $19.9M | ||
| Q2 25 | $-20.4M | $20.1M | ||
| Q1 25 | $-20.5M | $17.4M | ||
| Q4 24 | $-58.6M | $17.1M | ||
| Q3 24 | $-46.5M | $17.0M | ||
| Q2 24 | $-12.0M | $16.1M | ||
| Q1 24 | $-18.7M | $12.8M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 12.6% |
| Q4 25 | -40.0% | 2.3% | ||
| Q3 25 | -12.8% | 3.5% | ||
| Q2 25 | -9.6% | 3.3% | ||
| Q1 25 | -10.2% | 3.2% | ||
| Q4 24 | -37.4% | 2.5% | ||
| Q3 24 | -29.5% | 2.3% | ||
| Q2 24 | -8.3% | 2.9% | ||
| Q1 24 | -11.3% | 2.3% |
| Q4 25 | -19.6% | 2.2% | ||
| Q3 25 | -9.1% | 2.7% | ||
| Q2 25 | -5.7% | 2.5% | ||
| Q1 25 | -5.5% | 2.5% | ||
| Q4 24 | -15.8% | 2.3% | ||
| Q3 24 | -12.8% | 2.2% | ||
| Q2 24 | -3.2% | 2.2% | ||
| Q1 24 | -4.8% | 1.7% |
| Q4 25 | $-23.08 | $0.75 | ||
| Q3 25 | $-9.67 | $0.89 | ||
| Q2 25 | $-6.23 | $0.87 | ||
| Q1 25 | $-6.28 | $0.74 | ||
| Q4 24 | $-23.13 | $0.70 | ||
| Q3 24 | $-15.70 | $0.69 | ||
| Q2 24 | $-7.37 | $0.66 | ||
| Q1 24 | $-7.86 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.0M | $83.5M |
| Total DebtLower is stronger | $228.4M | — |
| Stockholders' EquityBook value | $-155.2M | $910.9M |
| Total Assets | $656.6M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.0M | $83.5M | ||
| Q3 25 | $37.7M | $124.9M | ||
| Q2 25 | $38.6M | $126.2M | ||
| Q1 25 | $40.1M | $146.3M | ||
| Q4 24 | $38.8M | $110.5M | ||
| Q3 24 | $63.0M | $145.0M | ||
| Q2 24 | $73.1M | $185.5M | ||
| Q1 24 | $27.3M | $159.1M |
| Q4 25 | $228.4M | — | ||
| Q3 25 | $252.8M | — | ||
| Q2 25 | $182.0M | — | ||
| Q1 25 | $171.1M | — | ||
| Q4 24 | $108.9M | — | ||
| Q3 24 | $133.2M | — | ||
| Q2 24 | $133.1M | — | ||
| Q1 24 | $118.1M | — |
| Q4 25 | $-155.2M | $910.9M | ||
| Q3 25 | $-18.7M | $914.0M | ||
| Q2 25 | $44.5M | $906.4M | ||
| Q1 25 | $63.3M | $901.7M | ||
| Q4 24 | $75.9M | $900.7M | ||
| Q3 24 | $120.5M | $920.9M | ||
| Q2 24 | $166.8M | $924.3M | ||
| Q1 24 | $146.6M | $944.1M |
| Q4 25 | $656.6M | $1.7B | ||
| Q3 25 | $683.6M | $1.7B | ||
| Q2 25 | $731.6M | $1.8B | ||
| Q1 25 | $783.9M | $1.7B | ||
| Q4 24 | $783.4M | $1.7B | ||
| Q3 24 | $833.3M | $1.8B | ||
| Q2 24 | $892.8M | $1.8B | ||
| Q1 24 | $855.9M | $1.8B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.09× | — | ||
| Q1 25 | 2.71× | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.80× | — | ||
| Q1 24 | 0.81× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.7M | $30.8M |
| Free Cash FlowOCF − Capex | — | $28.9M |
| FCF MarginFCF / Revenue | — | 3.8% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.87× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.7M | $30.8M | ||
| Q3 25 | $-15.4M | $23.2M | ||
| Q2 25 | $-16.6M | — | ||
| Q1 25 | $-33.5M | $66.1M | ||
| Q4 24 | $-57.2M | $-6.2M | ||
| Q3 24 | $-22.6M | $44.8M | ||
| Q2 24 | $-10.2M | — | ||
| Q1 24 | $-20.0M | $160.2M |
| Q4 25 | — | $28.9M | ||
| Q3 25 | — | $20.8M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $64.6M | ||
| Q4 24 | — | $-8.2M | ||
| Q3 24 | — | $42.5M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $157.7M |
| Q4 25 | — | 3.8% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 9.2% | ||
| Q4 24 | — | -1.1% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 21.0% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.0% | 0.2% | ||
| Q1 24 | 0.0% | 0.3% |
| Q4 25 | — | 1.87× | ||
| Q3 25 | — | 1.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.79× | ||
| Q4 24 | — | -0.36× | ||
| Q3 24 | — | 2.64× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 12.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
